VARICELLA ZOSTER VIRUS VACCINE

Use of an immunogenic composition comprising VZV gE, or immunogenic fragment thereof, and a TH-1 adjuvant in the preparation of a medicament for the prevention or amelioration of shingles and/or post herpetic neuralgia. Compositions comprising a truncated VZV gE antigen and an adjuvant containing QS...

Full description

Saved in:
Bibliographic Details
Main Authors STEPHENNE, JEAN, HANON, EMMANUEL JULES
Format Patent
LanguageEnglish
French
Published 27.03.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Use of an immunogenic composition comprising VZV gE, or immunogenic fragment thereof, and a TH-1 adjuvant in the preparation of a medicament for the prevention or amelioration of shingles and/or post herpetic neuralgia. Compositions comprising a truncated VZV gE antigen and an adjuvant containing QS21, cholesterol and 3D MPL are also claimed. Lutilisation dune composition immunogène comprenant VZV gE, ou un fragment immunogène de celui-ci, et un adjuvant TH-1 dans la préparation dun médicament pour la prévention ou lamélioration du zona ou de la névralgie post-herpétique. Des compositions contenant un antigène tronqué de VZV gE et un adjuvant contenant QS21, cholestérol et 3D MP sont également revendiquées.
AbstractList Use of an immunogenic composition comprising VZV gE, or immunogenic fragment thereof, and a TH-1 adjuvant in the preparation of a medicament for the prevention or amelioration of shingles and/or post herpetic neuralgia. Compositions comprising a truncated VZV gE antigen and an adjuvant containing QS21, cholesterol and 3D MPL are also claimed. Lutilisation dune composition immunogène comprenant VZV gE, ou un fragment immunogène de celui-ci, et un adjuvant TH-1 dans la préparation dun médicament pour la prévention ou lamélioration du zona ou de la névralgie post-herpétique. Des compositions contenant un antigène tronqué de VZV gE et un adjuvant contenant QS21, cholestérol et 3D MP sont également revendiquées.
Author STEPHENNE, JEAN
HANON, EMMANUEL JULES
Author_xml – fullname: STEPHENNE, JEAN
– fullname: HANON, EMMANUEL JULES
BookMark eNrjYmDJy89L5WSQC3MM8nR29fFxVIjyDw5xDVII8wwKDVYIc3R29vRz5WFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORhYWRkamps7GhFUAAA8ZIlU
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate VACCIN CONTRE LE VIRUS VARICELLE-ZONA
ExternalDocumentID CA2882255C
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2882255C3
IEDL.DBID EVB
IngestDate Fri Sep 27 05:21:46 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2882255C3
Notes Application Number: CA20062882255
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180327&DB=EPODOC&CC=CA&NR=2882255C
ParticipantIDs epo_espacenet_CA2882255C
PublicationCentury 2000
PublicationDate 20180327
PublicationDateYYYYMMDD 2018-03-27
PublicationDate_xml – month: 03
  year: 2018
  text: 20180327
  day: 27
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies GLAXOSMITHKLINE BIOLOGICALS S.A
RelatedCompanies_xml – name: GLAXOSMITHKLINE BIOLOGICALS S.A
Score 3.1439192
Snippet Use of an immunogenic composition comprising VZV gE, or immunogenic fragment thereof, and a TH-1 adjuvant in the preparation of a medicament for the prevention...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title VARICELLA ZOSTER VIRUS VACCINE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180327&DB=EPODOC&locale=&CC=CA&NR=2882255C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDLbGQMANBmi8Rg-otwrWZm12qFCXtlrRaKc9qonLlHSp4DImVsTfx41a4LJblEhOYsnx58T-AnBPOLepJbnBbbEyiOh3DZ7Z1OB9R3JKzExIlSAb28M5eV70Fg14q2thFE_otyJHRIvK0N4LdV5v_i6xfJVbuX0Q79j18RTOXF-vouMufbRMR_cHbjBO_ITpjLnM0-OJayKSRPTM9mC_BNEly36QDsqalM1_hxKewMEYZa2LU2jIdQuOWP3vWgsOX6rnbmxWlrc9g07qTSIWjEae9ppMEYNqaTSZT7XUYyyKg3O4C4MZGxo40fJ3T0vm1SuyLqCJkb5sg4bOktoYgohcUoLQRCi2mBwxRL4yezm5hPYuKVe7h67huNRMmThlOjfQLD6_5C160kJ0lBJ-AJe3dJ0
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT4MwEL_MaZxvOjXza-PB8EZ00AF7IIYVyFAGyz7I4svSshJ9mYvD-O97NEx92VvTJtf2kuv9rr37FeCeMGbahmAaM_lKI7zf1Vhm2hrrW4LZRM-4kAmysTmck-dFb1GDt10tjOQJ_ZbkiGhRGdp7Ic_rzd8llidzK7cP_B27Pp6CmeOpVXTctR8N3VK9geOPEy-hKqUOddV44uiIJBE90wM4tEpu3hI4pYOyJmXz36EEp3A0Rlnr4gxqYt2EBt39u9aE41H13I3NyvK259BO3UlI_ShylddkihhUScPJfKqkLqVh7F9AJ_BndKjhRMvfPS2pu1uRcQl1jPRFCxR0lraJIQjPhU0QmnDJFpMjhshXei8nV9DaJ-V6_1AHGsPZKFpGYfxyAyellsokKt26hXrx-SXu0KsWvC0V8gMzPXeK
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=VARICELLA+ZOSTER+VIRUS+VACCINE&rft.inventor=STEPHENNE%2C+JEAN&rft.inventor=HANON%2C+EMMANUEL+JULES&rft.date=2018-03-27&rft.externalDBID=C&rft.externalDocID=CA2882255C